Development of a broad spectrum polymer-released antimicrobial coating for the prevention of resistant strain bacterial infections

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 10, 2012, Pages 2732-2738

  Sinclair, K D ^a,b   Pham, T X ^b   Farnsworth, R W ^b   Williams, D L ^a,b   Loc Carrillo, C ^a,b   Horne, L A ^b   Ingebretsen, S H ^b   Bloebaum, R D ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

antimicrobial agents; ceragenin; controlled release device; CSA 13; drug delivery

Indexed keywords

ANTI-MICROBIAL AGENT; ANTIMICROBIAL COATINGS; BACTERIAL INFECTIONS; BROAD SPECTRUM; CERAGENIN; COLONY FORMING UNITS; CONTROLLED RELEASE DEVICES; CSA-13; IN-VITRO; IN-VIVO; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PATIENT CARE; POLYMERIC DEVICES; RESISTANT STRAINS; REVISION SURGERY; SHEEP MODEL;

BACTERIA; DRUG DELIVERY; POLYMERS; SILICONES; SURGERY;

PLASTIC COATINGS;

ANTIBIOTIC AGENT; CSA 13; POLYMER; SILICONE; TITANIUM; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; COLONY FORMING UNIT; CONTROLLED DRUG RELEASE; DRUG COATING; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PARTICLE SIZE;

ANTI-INFECTIVE AGENTS; COATED MATERIALS, BIOCOMPATIBLE; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, BACTERIAL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; POLYMERS; POROSITY; STAPHYLOCOCCAL INFECTIONS; STEROIDS; TIME FACTORS;

EID: 84865658077     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34209     Document Type: Article

References (25)

1. Mason JB,. The new demands by patients in the modern era of total joint arthroplasty. Clin Orthop Relat Res 2008; 466: 146-152. (Pubitemid 351903864)
2. Parvizi J, Pawasarat IM, Azzam KA, Joshi A, Hansen EN, Bozic KJ,. Periprosthetic joint infection the economic impact of methicillin-resistant infections. J Arthroplast 2010; 25: 103-107.
3. Darwiche H, Barsoum WK, Klika A, Krebs VE, Molloy R,. 2010. Retrospective analysis of infection rate after early reoperation in total hip arthroplasty. Clin Orthop Relat Res 2010; 468: 2392-2396.
4. Haenle M, Fritshce A, Zietz C, Bader R, Heidenau F, Mittelmeier W, Gollwitzer,. An extended spectrum bactericidal titanium dioxide (TiO2) coating for metallic implants: in vitro effectiveness against MRSA and mechanical properties. J Mater Sci: Mater Med 2011; 22: 381-387.
5. Parvizi J, Ghanem E, Azam K, Davis E, Jaberi F, Hozack W,. Periprosthetic infection: are current treatment strategies adequate? Acta Ortop Belg 2008; 74: 793-800.
6. Cosgrove SE, Carroll KC, Perl TM,. Staphylococcus aureus with reduced susceptibility to vancomycin. Clin Infect Dis 2004; 39: 539-545. (Pubitemid 39120931)
7. Hancock RE,. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis 2001; 1: 156-164. (Pubitemid 33586049)
8. Epand RF, Pollard JE, Wright JO, Savage PB, Epand RM,. Depolarization, bacterial membrane composition, and the antimicrobial action of ceragenins. Antimicrob Agents Chemother 2010; 54: 3708-3713.
9. Bucki R, Sostarecz AG, Byfield FJ, Savage PB, Janmey PA,. Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA of F-actin, and its activity in cystic fibrosis sputum. J Antimicrob Chemother 2007; 60: 535-545. (Pubitemid 47299867)
10. Chin JN, Rybak MJ, Cheung CM, Savage PB,. Antimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureus. Antimicrob Agents Chemother 2007; 51: 1268-1273. (Pubitemid 46586804)
11. Savage PB, Li C, Taotafa U, Ding B, Guan Q,. Antibacterial properties of cationic steroid antibiotics. FEMS Microbiol Lett 2002; 217: 1-7. (Pubitemid 35356536)
12. Savage PB,. Design, synthesis and characterization of cationic peptide and steroid antibiotics. Eur J Org Chem 2002; 759-768.
13. Savage PB, Li C, Taotafa U, Ding B, Guan Q,. Antibacterial properties of cationic steroid antibiotics. Fed Eur Microbiol Soc Lett 2002; 217: 1-7. (Pubitemid 35356536)
14. Savage PB,. Multidrug resistant bacteria: overcoming antibiotic permeability barriers of gram-negative bacteria. Ann Intern Med 2001; 33: 167-171. (Pubitemid 32417619)
15. Chin JN, Jones RN, Sader HS, Savage PB, Rybak MJ,. Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa. J Antimicrob Chemother 2008; 61: 365-370.
16. Bucki R, Namiot DB, Namiot Z, Savage PB, Janmey PA,. Salivary mucins inhibit antibacterial activity of cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13. J Antimicrob Chemother 2008; 62: 329-335. (Pubitemid 351984776)
17. Hill PF, Clasper JC, Parker SJ, Watkins PE,. Early intramedullary nailing in an animal model of a heavily contaminated fracture of the tibia. J Orthop Res 2002; 20: 648-653. (Pubitemid 34822982)
18. Clasper JC, Stapley SA, Bowley DMG, Kenward CE, Taylor V, Watkins PE,. Spread of infection, in an animal model, after intramedullary nailing of an infected external fixator pin track. J Orthop Res 2001; 19: 155-159. (Pubitemid 32288650)
19. Dey BP, Engley Jr. FB,. Neutralization of antimicrobial chemicals by recovery media. J Microbiol Methods 1994; 19: 51-58. (Pubitemid 24037104)
20. Dey BP, Engley Jr. FB,. Comparison of Dey and Engley (D/E) neutralizing medium to letheen medium and standard methods medium for recovery of Staphylococcus aureus from sanitized surfaces. J Ind Microbiol 1995; 14: 21-25.
21. Pollard J, Wright J, Feng Y, Geng D, Genberg C, Savage PB,. Activities of ceragenin CSA-13 against established biofilms in an in vitro model of catheter decolonization. Anti-Infect Agent Med Chem 2009; 8: 290-294.
22. Fletcher N, Sofianos D, Berkes MB, Obremskey WT,. Prevention of perioperative infection. J Bone Joint Surg 2007; 89: 1605-1618. (Pubitemid 47041540)
23. Jacobs MR,. Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamics parameters. Clin Microbiol Infect 2001; 7: 589-596. (Pubitemid 34960355)
24. Ambrose PG, Bhavnani SM, Rubino CM, Louie A, Gumbo T, Forrest A, Drusano GL,. Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore. Antimicrob Resist 2007; 44: 79-86. (Pubitemid 44968990)
25. Isogai E, Isogai H, Takahashi K, Okumura K, Savage PB,. Ceragenin CSA-13 exhibits antimicrobial activity against cariogenic and periodontopathic bacteria. Oral Microbiol Immunol 2009; 24: 170-172.